Back
FibroGen, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
FGEN
FibroGen, Inc.
Last Price:
$8.30
Seasonality Move:
26.36%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FGEN is experiencing slight selling pressure.
FibroGen, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.47 | Sell |
| 20-day SMA: | 9.01 | Sell |
| 50-day SMA: | 10.35 | Sell |
| 200-day SMA: | 9.06 | Sell |
| 8-day EMA: | 8.42 | Sell |
| 20-day EMA: | 8.98 | Sell |
| 50-day EMA: | 9.75 | Sell |
| 200-day EMA: | 11.21 | Sell |
FibroGen, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 30.6 | Sell |
| Chaikin Money Flow: | -1783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.25 - 10.57) | Sell |
| Bollinger Bands (100): | (8.38 - 11.76) | Sell |
FibroGen, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for FibroGen, Inc. Stock
Is FibroGen, Inc. Stock a Buy?
-
FibroGen, Inc. share price is 8.25 while FGEN 8-day simple moving average is 8.47, which is a Sell signal.
-
The stock price of FGEN is 8.25 while FibroGen, Inc. 20-day SMA is 9.01, which makes it a Sell.
-
FibroGen, Inc. 50-day simple moving average is 10.35 while FGEN share price is 8.25, making it a Sell technically.
-
FGEN stock price is 8.25 and FibroGen, Inc. 200-day simple moving average is 9.06, creating a Sell signal.
FGEN Technical Analysis vs Fundamental Analysis
Sell
35
FibroGen, Inc. (FGEN)
is a Sell
Is FibroGen, Inc. a Buy or a Sell?
-
FibroGen, Inc. stock is rated a SellThe current FibroGen, Inc. [FGEN] share price is $8.25. The Score for FGEN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
FibroGen, Inc. Stock Info
Market Cap:
33.3M
Price in USD:
8.25
Share Volume:
25K
FibroGen, Inc. 52-Week Range
52-Week High:
21.94
52-Week Low:
4.85
Sell
35
FibroGen, Inc. (FGEN)
is a Sell
FibroGen, Inc. Share Price Forecast
-
What is the FibroGen, Inc. stock price today?The FibroGen, Inc. stock price is 8.25 USD today.
-
Will FGEN stock go up or go down?FibroGen, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is FibroGen, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, FibroGen, Inc. is overvalued.
Is FibroGen, Inc. Stock a Buy?
-
FibroGen, Inc. share price is 8.25 while FGEN 8-day exponential moving average is 8.42, which is a Sell signal.
-
The stock price of FGEN is 8.25 while FibroGen, Inc. 20-day EMA is 8.98, which makes it a Sell.
-
FibroGen, Inc. 50-day exponential moving average is 9.75 while FGEN share price is 8.25, making it a Sell technically.
-
FGEN stock price is 8.25 and FibroGen, Inc. 200-day simple moving average is 11.21, creating a Sell signal.
Fundamental Analysis of FibroGen, Inc.
Is FibroGen, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.33 per share, and a decrease next year of $10.95 per share.
Technical Analysis of FibroGen, Inc.
Should I short FibroGen, Inc. stock?
-
FGEN Moving Average Covergence Divergence (MACD) indicator is -0.63, suggesting FibroGen, Inc. is a Sell
-
FibroGen, Inc. Relative Strength Index (RSI) is 30.6, which suggest FibroGen, Inc. is oversold
-
The Bollinger Bands (25) for FibroGen, Inc. is (8.25 - 10.57), which suggest FibroGen, Inc. is a Sell
-
The Bollinger Bands (100) for FibroGen, Inc. is (8.38 - 11.76), which suggest FibroGen, Inc. is a Sell
* FibroGen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.